Related Experiment Video
Updated: Jun 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Vaccination strategies against myxomavirus infections: are we really doing the best?
1Department of Bird, Rabbit and Rodent Medicine, Faculty of Veterinary Medicine, University of Liège, Bld de Colonster 20, Bat B42, Sart-Tilman, B4000 Liège.
Abstract:
Vaccination is the best way to control myxomatosis in both pet and production rabbits. Two types of myxomatosis vaccines are commercially available, namely, a vaccine prepared from the Shope fibroma virus (SFV) and one prepared from an attenuated myxoma virus (MV) strain, e.g., SG33. The first one is weakly immunogenic and provides only short-term protection whereas atypical reactions have been described with the second one. This short review describes the vaccine strains and provides some data on the host-virus relationship, resistance, and immunity in myxomatosis. In the last section, recommended myxomatosis vaccination schemes for production and pet animals are presented.
Related Concept Videos
Smallpox
Vaccines
Vaccinations
Microorganisms in Medicine and Therapeutics
Poliomyelitis
Respiratory Syncytial Virus Disease

